BASILEA PHARMACEU financial statements, including revenue, expenses, and profit

The total revenue of PK5 for the last semiannual is 132.25 M CHF, and it's 73.34% higher compared to the previous semiannual. The net income of H2 24 is 56.86 M CHF.